Kalaris Therapeutics, Inc.
Biotechnology company · Berkeley Heights, New Jersey, United States · Nasdaq: KLRS
Kalaris Therapeutics, Inc. is a biotechnology company headquartered in Berkeley Heights, New Jersey, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker KLRS. It has reported private securities offerings to the US SEC, most recently $121 million sold in a notice filed in 2019.
Kalaris Therapeutics at a glance
What does Kalaris Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $121.3 million sold (2019).
Frequently asked questions about Kalaris Therapeutics
Where is Kalaris Therapeutics headquartered?
Kalaris Therapeutics, Inc. is headquartered in Berkeley Heights, New Jersey, United States.
What does Kalaris Therapeutics do?
Kalaris Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Kalaris Therapeutics a public company?
Yes. Kalaris Therapeutics, Inc. trades on Nasdaq under the ticker KLRS.
When was Kalaris Therapeutics founded?
The earliest incorporation on record for Kalaris Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.